Cumberland Pharmaceuticals (CPIX) closed at $7.96 on October 20, 2026, up 18.8% from the previous close, on volume of 102,208 shares (30-day average 41,665).
Data as of October 20, 2026.
20-Oct-2026
CUMBERLAND PHARMACEUTICALS ANNOUNCES NATIONAL CALL TO PRESENT AN UPDATE ON ITS IFETROBAN DMD PROGRAM
PRNewswire (Mon, 19-Oct 4:07 PM ET)
CUMBERLAND PHARMACEUTICALS REPORTS COMPANY UPDATE & Q2 2026 FINANCIAL RESULTS
PRNewswire (Tue, 4-Aug 5:06 PM ET)
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE COMPANY UPDATE & Q2 2026 FINANCIAL RESULTS
PRNewswire (Tue, 28-Jul 4:05 PM ET)
CPIX: New RedHill Data Spotlights Opaganib’s Potential in Neuroblastoma and Breast Cancer Therapy
Market Chameleon (Thu, 23-Apr 5:52 AM ET)
CPIX Sells Commercial Portfolio to Apotex in $100 Million Deal—New Focus on Orphan Drug Development
Market Chameleon (Thu, 23-Apr 5:33 AM ET)
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.
Cumberland Pharmaceuticals trades on the NASDAQ stock market under the symbol CPIX.
As of October 20, 2026, CPIX stock price climbed to $7.96 with 102,208 million shares trading.
CPIX has a beta of 1.72, meaning it tends to be more sensitive to market movements. CPIX has a correlation of 0.04 to the broad based SPY ETF.
CPIX has a market cap of $119.27 million. This is considered a Micro Cap stock.
In the last 3 years, CPIX traded as high as $9.28 and as low as $1.04.
The top ETF exchange traded funds that CPIX belongs to (by Net Assets): VTI, VXF, DFAS, DFMC, IWC.
CPIX has outperformed the market in the last year with a price return of +175.0% while the SPY ETF gained +16.9%. CPIX has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +38.3% and +12.3%, respectively, while the SPY returned +3.7% and -0.7%, respectively.
CPIX support price is $6.29 and resistance is $7.11 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CPIX shares will trade within this expected range on the day.
